7.4 Nonprescription Products, Methamphetamine Precursors & Schedule V Exempt Narcotics

7.4 Nonprescription Products: Behind-the-Counter Sales, Methamphetamine Precursors & Exempt Narcotics

MPJE Competency 3.8 covers "requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs." Candidates routinely under-prepare this area because it feels like retail, not pharmacy. It is heavily tested precisely because two product classes sit in an awkward legal space: they need no prescription, yet they may only be sold by pharmacy personnel, under quantity caps, with identification and a permanent record.

Virginia layers its own statute on top of the federal scheme for both classes. Where the two differ, the stricter rule controls — and on the Virginia MPJE, the Virginia number is usually the answer.

---

1. Methamphetamine Precursors: Ephedrine & Pseudoephedrine

The Federal Floor — Combat Methamphetamine Epidemic Act (CMEA) of 2005

The CMEA moved pseudoephedrine (PSE), ephedrine, and phenylpropanolamine out of open shelf stock and created a federal "scheduled listed chemical product" regime under 21 U.S.C. § 830(e):

• Placement: behind the counter or in a locked cabinet.
• Daily limit: 3.6 g of base per purchaser per calendar day.
• 30-day limit: 9 g at retail; 7.5 g for mail-order and mobile retail vendors.
• Logbook: name, address, product, quantity, date and time of sale, and purchaser signature; retained two years.
• Photo identification required.
• Seller self-certification to DEA plus documented employee training.

The Virginia Overlay — Va. Code § 18.2-265.7

The base-weight trap. A 24-count box of 30 mg pseudoephedrine tablets weighs far more than 720 mg, but the regulated quantity is 720 mg of PSE base. Exam items that hand you a product weight are testing whether you convert to base. Total base = strength per unit × number of units.

Three Exemptions Worth Memorizing

1. Prescription products. Ephedrine or related compounds dispensed on a valid prescription are exempt from the sales limits, the ID requirement, and the recordkeeping requirements entirely. A prescription converts the transaction into ordinary dispensing.
2. The 60 mg isolated sale. The sale of a single package containing not more than 60 milligrams of ephedrine or related compounds need not be entered in the log or reported, provided it is an isolated sale.
3. Low-volume retailers. A retail distributor maintaining a sales volume of less than 72 grams per 30-day period may fall within the § 18.2-265.11 exemption from electronic reporting.

The Stop-Sale Alert and Override

Under § 18.2-265.9, the electronic system must generate a stop sale alert when completing the transaction would breach the quantity limits. An override function exists for the narrow circumstances the statute specifies, and every use of the override is recorded. Overriding a stop-sale alert to accommodate a customer who has simply hit the 30-day cap is not one of those circumstances — that is a knowing sale over the limit.

---

2. Schedule V Exempt Narcotics Sold Without a Prescription

Virginia is one of the states that still permits a pharmacist to sell certain Schedule V narcotic preparations without a prescription. This is governed by Va. Code § 54.1-3416, and the conditions are cumulative — failing any one makes the sale unlawful.

The 48-Hour Quantity Ceilings

No more than the following may be dispensed to any one person within 48 consecutive hours:

The Non-Quantity Conditions

• The preparation is dispensed only by a pharmacist, directly to the person requesting it — a technician may not complete the sale, and it may not be left for pickup.
• The purchaser must be at least 18 years of age.
• The pharmacist must require suitable identification, including proof of age where appropriate.
• The pharmacist must exercise professional discretion to satisfy himself that the preparation is being sold for medical purposes only. A purchaser presenting at 48-hour intervals with escalating requests is not buying for a medical purpose, and the pharmacist's discretion is the legal control point.

PMP interaction — a favorite distractor. Va. Code § 54.1-2519 defines "covered substance" to include "controlled substances in Schedule V for which a prescription is required." An exempt-narcotic Schedule V sale made without a prescription therefore falls outside that definition and is not a PMP-reportable dispensing. The pharmacy's own § 54.1-3416 record is what documents it. Do not confuse this with gabapentin, which is a Virginia Schedule V requiring a prescription and is fully PMP-reportable.

---

3. Nonprescription Products That Are Hazardous Drugs

Competency 3.8 also reaches hazardous drugs, and the trap is assuming that "no prescription required" means "no handling controls." It does not. USP <800> applies based on the drug's entry on the NIOSH hazardous drug list, not on its prescription status. An OTC or behind-the-counter product on that list still requires the assessment of risk, personal protective equipment, and segregated handling described in Section 10.3 of this guide.

Two practical consequences in a Virginia community pharmacy:

• Counting and repackaging a hazardous product on the NIOSH list may not be done on the general counting tray, regardless of whether the sale required a prescription.
• Spill and disposal procedures follow the pharmacy's USP <800> assessment of risk and Virginia's disposal rules, not ordinary solid-waste handling.

---

Putting the Channels Side by Side

The through-line for the exam: as the abuse potential rises, the statute narrows who may hand over the product, how much, to whom, and what must be written down — while never requiring a prescription.